Andrea earned her B.S. in Biotechnology and M.S. in Biology and then began her career in the lab working on process development and validation before transitioning to a quality role. Andrea has spent time in Quality Systems, Compliance, and Operations positions but now specializes in leading a QA Operations team supporting the CMC functions of early phase clinical programs through commercialization.
Archives: Speakers
Michail Mogilevski
Michail Mogilevski serves as the Head of Green Technology and Healthcare at PEAC Solutions, leveraging over a decade of invaluable experience in the financial services industry. With a stellar track record in business development, international vendor finance, and credit risk management, Michail’s expertise encompasses Healthcare, including Medical Technology and Fitness, as well as Green Mobility & Energy Solutions. His unwavering commitment to driving innovation and sustainability, coupled with his visionary approach, positions him as a catalyst for transformative solutions at the intersection of finance and impactful industries.
Vinay Patil
As Manager of Product development Services at Sharp, Vinay is responsible for supporting R&D formulations by leading a team of scientists and product development leading to CTM manufacturing of products for clinical studies and subsequent regulatory filings. Vinay has over 7 years of R&D experience and clinical trials. He has started his career as Formulation Scientists and worked over more than 50 projects which includes NDAs and ANDAs throughout his career journey over the course of his career and has expertise in oral solid dosage form.
Vinay holds master’s degree in industrial pharmacy from University of Long Island, NY and a bachelor’s degree in Pharmaceutics from Pune University, India.
Rob Feltz
As the Director of Analytical and Formulation Services, Robert is responsible for leadership of product development, GMP manufacturing, and analytical laboratory personnel. Robert has over 18 years of QC and R&D experience in the pharmaceutical industry as a subject matter expert in CMC sections of regulatory submissions. He also serves as a primary scientific reviewer on third-party research and development projects and provides expert guidance on identifying chemical degradation pathways, impurity purification, and qualification.
Adrien Sicard
Chris Casazza
Chris Casazza is an executive team leader with over two decades of experience driving commercial success and R&D excellence in the Pharma and Biotech sectors. Chris has held pivotal leadership roles at Kantar Health (now part of Oracle Life Sciences), YourEncore, and Advarra. In his current role as Chief Commercial Officer at Diligent Pharma, Chris manages all commercial aspects of the company’s operations and is deeply involved in growing the vision and culture of the company.
Dr. Katalin Varga-Toldi
Segment & customer management leader with over 15 years of experience in developing segment-tailored value propositions, driving segment growth strategies and creating differentiated client handling solutions for financial services. Skilled at leading high-performing business development & segment teams and executing integrated segment and client retention strategy programs. A creative, out-of-the-box thinker with passion for leading change with growth mindset and creating a nurturing culture of innovation.
John Glennane
John Glennane, CEO and founder of Capventis, has been pursuing the goal of aligning technology and systems to serve the real-world needs of people and business for over 35 years. In 1999 he established Capventis, to help organisations and people deliver more value through the strategic use of data and ideas. The ideas, issues and imperatives that start us off on the journey to value, all need consideration, knowledge, skills, resources, structure, rigour and good design. The resulting solutions also need appropriate technology, combined with experience to make them viable and successful. John’s mission today is to empower a new generation of our smartest and best-educated people to be equipped with next-generation technology (‘Glu’) and the knowledge, skills and freedom to drive step-change improvement in our most critical public and private sector organisations.
Jim Eamma
Jim Eamma’s experience in scientific and clinical research spans more than two decades and includes work in academic, clinical and CRO settings. Although oncology is his primary area of focus, he has also worked on clinical trials in other therapeutic areas. His intimate knowledge of studies at the level of the investigative site gives him the logistical and practical perspective needed for effective leadership and oversight. Today Jim will share more about Worldwide Clinical Trials and how the Worldwide team can help with your oncology trials.